FDA accepting grant applications for new drugs to treat minor speciesNovember 27, 2018The U.S. Food and Drug Administration (FDA) is accepting applications for grants to support the development of new animal drugs intended to treat uncommon diseases in major or minor species (MUMS).
Education Center - SponsoredVector-Borne Disease Coming to a Neighborhood Near You: Which Tests to Reach For, and Why?by • AntechWhether it’s a screening to identify exposure to tick-borne pathogens, or a broad molecular diagnostic panel to help with acute disease detection or confirm the presence of genetic material, these options empower veterinary teams, guide treatment, and support antimicrobial stewardship.
